Global Pricing Innovations supports price decision-making through data-driven insights and bespoke analytical solutions. GPI tools and services maximize clients’ price and value understanding and ...

Veradermics has announced positive topline results from its open-label phase 2 clinical trial (Study ‘207’) evaluating ...

Following ASCO® 2026, Inizio's experts have shared their perspectives across three thought leadership articles, each ...

Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with ...

Independent healthcare communications consultancy POP Health has appointed Stephanie O’Hagan as Senior Director. O’Hagan has ...

The phrase "patient-centered care" is tossed around freely in healthcare corporate boardrooms. Yet, for more than half the ...

As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain ...

AstraZeneca has entered into an exclusive licence agreement with Dizal Pharmaceutical for Zegfrovy (sunvozertinib), a novel ...

Bristol Myers Squibb’s New Drug Application (NDA) for mezigdomide has been accepted by the US FDA. Mezigdomide is an oral ...

The unique combination of technology marks 25 years of industry innovation and expertise, and signals company’s next phase of ...

Cherry, a full-service creative healthcare agency, has appointed Peter Henshaw as Managing Director. Henshaw will be ...

Launching prescription medicines excellently – achieving optimal commercial performance that reflects a medicine’s value and ...